Phalipon, A., & Mulard, L. A. (2022, March). Toward a Multivalent Synthetic Oligosaccharide-Based Conjugate Vaccine against <i>Shigella</i>: State-of-the-Art for a Monovalent Prototype and Challenges. Vaccines.
Chicago Style (17th ed.) CitationPhalipon, Armelle, and Laurence A. Mulard. "Toward a Multivalent Synthetic Oligosaccharide-Based Conjugate Vaccine Against Shigella: State-of-the-Art for a Monovalent Prototype and Challenges." Vaccines Mar. 2022.
MLA (9th ed.) CitationPhalipon, Armelle, and Laurence A. Mulard. "Toward a Multivalent Synthetic Oligosaccharide-Based Conjugate Vaccine Against Shigella: State-of-the-Art for a Monovalent Prototype and Challenges." Vaccines, Mar. 2022.
Warning: These citations may not always be 100% accurate.
